Skip to main content

Advertisement

SpringerLink
Log in

Overexpression of autotaxin is associated with human renal cell carcinoma and bladder carcinoma and their progression

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Autotaxin (ATX) as an important tumor cell motility-stimulating factor is upregulated in many different types of cancer. ATX, a member of the ectonucleotide pyrophosphatase and phosphodiesterase family of enzymes, possesses lysophospholipase D activity which hydrolyzes lysophosphatidylcholine to generate the potent tumor growth factor and mitogen lysophosphatidic acid (LPA). LPA acts on specific G-protein-coupled receptors, thereby regulating cell growth, migration, and survival. This study aimed to investigate the differences in gene expression pattern of ATX between cancerous and adjacent normal tissue of human renal cell carcinoma (RCC) and bladder carcinoma (BC) and find the correlation between ATX expression and clinicopathological features of both of these carcinomas. Both the RCC and BC tissues and with the adjacent normal tissues were collected. Immunohistochemistry and Western blotting analysis were used to detect the extent of ATX expression in all of these samples. Immunohistochemistry and Western blot analysis revealed that expression of ATX protein in carcinoma tissues is significantly higher than that in the adjacent normal tissues. Immunohistochemistry analysis showed that ATX is localized in cytoplasm. Western blotting analysis showed that ATX protein is expressed in both RCC and BC, and the expression levels were 69.5 and 48.0 %, respectively, higher in RCC and BC carcinoma tissue samples than in the adjacent normal tissues, which is consistent with the results of immunohistochemistry study. Thus, this study provided the evidence that ATX is highly expressed in both RCC and BC. Further research can be done to identify the diagnosis and treatment significance of both these carcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jena J. A study on natural anticancer plants. Int J Pharm Chem Sci. 2012;1(1):365–8.

    Google Scholar 

  2. Global Burden of Disease Cancer Collaboration. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.

    Article  PubMed Central  Google Scholar 

  3. Robins SL, Cotran RS. Neoplasia. In: Kumar V, Abbas AK, Fausto N, editors. Pathologic basis of disease. 7th ed. India: Thomson Press; 2009. p. 292–306.

    Google Scholar 

  4. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol Off J Eur Soc Med Oncol/ESMO. 2007;18:581–92.

    Article  CAS  Google Scholar 

  5. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

    Article  PubMed  Google Scholar 

  6. Kim SS, Choi YD, Shim MK, Kim J, Cho YM, Jang JJ, Park RJ, Juhng SW, Choi C. Microscopic and nuclear morphometric findings of chromophobe renal cell carcinoma, renal oncocytoma, and tumor with overlapping histology. Ann Diagn Pathol. 2012;16:429–35.

    Article  PubMed  Google Scholar 

  7. Lotan Y, Karam JA, Shariat SF, Gupta A, Roupret M, Bensalah K, Margulis V. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. Urol Oncol. 2015;. doi:10.1016/j.urolonc.2015.10.011.

    Google Scholar 

  8. Solomon James P, Hansel Donna E. Morphologic and molecular characteristics of bladder cancer. Surg Pathol. 2015;8:663–76.

    Article  Google Scholar 

  9. Burger M, Catto JWF, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234–41.

    Article  PubMed  Google Scholar 

  10. Cholia RP, Nayyar H, Kumar R, Mantha AK. Understanding the multifaceted role of ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2) and its altered behaviour in human diseases. Curr Mol Med. 2015;15(10):932–43.

    Article  CAS  PubMed  Google Scholar 

  11. Tania M, Khan MA, Zhang H, Li J, Song Y. Autotaxin: a protein with two faces. Biochem Biophys Res Commun. 2010;401:493–7.

    Article  CAS  PubMed  Google Scholar 

  12. Fotopoulou S, Oikonomou N, Grigorieva E, et al. ATX expression and LPA signalling are vital for the development of the nervous system. Dev Biol. 2010;339:451–64.

    Article  CAS  PubMed  Google Scholar 

  13. Ptaszynska MM, Pendrak ML, Bandle RW, Stracke ML, Roberts DD. Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells. Mol Cancer Res. 2008;6:352–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Leblanc R, Lee SC, David M, Bordet JC, Norman DD, Patil R, Miller D, Sahay D, Ribeiro J, Clézardin P, Tigyi GJ, Peyruchaud O. Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone. Blood. 2014;124(20):3141–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ortlepp C, Steudel C, Heiderich C, Koch S, Jacobi A, Ryser M, Brenner S, Bornhäuser M, Brors B, Hofmann WK, Ehninger G, Thiede C. Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation. Exp Hematol. 2013;41(5):444–6.

    Article  CAS  PubMed  Google Scholar 

  16. Baumforth KR, Flavell JR, Reynolds GM, Davies G, Pettit TR, Wei W, Morgan S, Stankovic T, Kishi Y, Arai H, Nowakova M, Pratt G, Aoki J, Wakelam MJ, Young LS, Murray PG. Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Blood. 2005;106(6):2138–46.

    Article  CAS  PubMed  Google Scholar 

  17. Alshenawy HA. Immunohistochemical panel for differentiating renal cell carcinoma with clear and papillary features. J Microsc Ultrastruct. 2015;3:68–74.

    Article  Google Scholar 

  18. Moch H, Artibani W, Delahunt B, Ficarra V, Knuechel R, Montorsi F, Patard JJ, Stief CG, Sulser T, Wild PJ. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol. 2009;56(4):636–43.

    Article  PubMed  Google Scholar 

  19. Sun M, Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Pharand D, Latour M, Perrotte P, Patard JJ, Karakiewicz PI. A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Eur Urol. 2009;56(5):775–81.

    Article  PubMed  Google Scholar 

  20. Meskawi M, Sun M, Trinh QD, Bianchi M, Hansen J, Tian Z, Rink M, Ismail S, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI. A review of integrated staging systems for renal cell carcinoma. Eur Urol. 2012;62(2):303–14.

    Article  PubMed  Google Scholar 

  21. Ficarra V, Novara G, Martignoni G. The use of simplified versions of the Fuhrman nuclear grading system in clinical practice requires the agreement of a multidisciplinary panel of experts. Eur Urol. 2009;56(5):782–4.

    Article  PubMed  Google Scholar 

  22. Van Meeteren LA, Ruurs P, Christodoulou E, Goding JW, Takakusa H, Kikuchi K, Perrakis A, Nagano T, Moolenaar WH. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J Biol Chem. 2005;280(22):21155–61.

    Article  PubMed  Google Scholar 

  23. Moolenaar WH, Houben AJ, Lee SJ, van Meeteren LA. Autotaxin in embryonic development. Biochim Biophys Acta. 2013;1831(1):13–9.

    Article  CAS  PubMed  Google Scholar 

  24. Stein AJ, Bain G, Prodanovich P, Santini AM, Darlington J, Stelzer NM, Sidhu RS, Schaub J, Goulet L, Lonergan D, Calderon I, Evans JF, Hutchinson JH. Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding. Mol Pharmacol. 2015;88(6):982–92.

    Article  CAS  PubMed  Google Scholar 

  25. Tokuhara Y, Kurano M, Shimamoto S, Igarashi K, Nojiri T, Kobayashi T, Masuda A, Ikeda H, Nagamatsu T, Fujii T, Aoki J, Yatomi Y. A new enzyme immunoassay for the quantitative determination of classical autotaxins (ATXα, ATXβ, and ATXγ) and novel autotaxins (ATXδ and ATXε). PLoS One. 2015;10(6):e0130074.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Stassar MJ, Devitt G, Brosius M, Rinnab L, Prang J, Schradin T, Simon J, Petersen S, Kopp-Schneider A, Zöller M. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer. 2001;85(9):1372–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Benesch MG, Ko YM, McMullen TP, Brindley DN. Autotaxin in the crosshairs: taking aim at cancer and other inflammatory conditions. FEBS Lett. 2014;588:2712–27.

    Article  CAS  PubMed  Google Scholar 

  28. Kataoka M, Ishibashi K, Kumagai S, Yanagida T, Aikawa K, Chiba H, Kojima Y. Expression and function of LPA1 in bladder cancer. J Urol. 2015;194(1):238–44.

    Article  CAS  PubMed  Google Scholar 

  29. Houben Anna J S, Moolenaar Wouter H. Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev. 2011;30:557–65.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The work was supported by the Grant 81071685 from the National Natural Science Foundation of China.

Author information

Author notes

    Authors and Affiliations

    1. Colin Ratledge Center for Microbial Lipids, School of Agriculture Engineering and Food Science, Shandong University of Technology, Zibo, China

      Aihua Xu, Md. Ahsanul Kabir Khan & Yuanda Song

    2. Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China

      Fangzhi Chen & Zhaohui Zhong

    3. Department of Biochemistry, School of Life Sciences and The State Key Laboratory of Medical Genetics, Central South University, Changsha, 410013, Hunan, China

      Aihua Xu, Han-chun Chen & Yuanda Song

    Authors
    1. Aihua Xu
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Md. Ahsanul Kabir Khan
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Fangzhi Chen
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Zhaohui Zhong
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Han-chun Chen
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Yuanda Song
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding authors

    Correspondence to Han-chun Chen or Yuanda Song.

    Ethics declarations

    Conflict of interest

    The authors declare no conflicts of interest in relation to the publication of this study. The authors have full control of all of the primary data and agree to allow the journal to review the data if needed.

    Ethical standards

    This study was approved by the medical ethics committee of the Xiangya Second Hospital of Central South University hospital.

    Informed consent

    For the use of all clinical materials for research purposes, prior written patient’s consent and approval from the Institute Research Ethics Committee were obtained.

    Additional information

    Aihua Xu and Md. Ahsanul Kabir Khan contributed equally to this work and are considered as first author.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Xu, A., Ahsanul Kabir Khan, M., Chen, F. et al. Overexpression of autotaxin is associated with human renal cell carcinoma and bladder carcinoma and their progression. Med Oncol 33, 131 (2016). https://doi.org/10.1007/s12032-016-0836-7

    Download citation

    • Received:

    • Accepted:

    • Published:

    • DOI: https://doi.org/10.1007/s12032-016-0836-7

    Keywords

    Search

    Navigation